The future and safety of ambulatory surgery by Glass, P S
SASA Refresher Course Texts: The future and safety of ambulatory surgery
59 2014;20(1)South Afr J Anaesth Analg
Introduction
This article will review the history of ambulatory anaesthesia 
and the drivers that are responsible for its growth. It will 
also review the present status and safety of ambulatory 
anaesthesia and the future of ambulatory anaesthesia.
Growth of ambulatory surgery and 
anaesthesia
James Nicoll documented the successful administration 
of 8 988 ambulatory anaesthetics in England from 1899-
1908.1 The next major step was quite remarkable. In 
1918, Ralph Waters opened an outpatient facility in Sioux 
City, Iowa.1 However, during the first half of 19th century, 
anaesthesia and surgery successes led to a greater trend 
towards hospitalisation, and away from outpatient surgery. 
In 1962, ULCA (the Neuropsychiatric Institute and Hospital) 
opened an outpatient surgical clinic within the hospital. 
In1966, George Washington University Hospital opened 
its ambulatory surgical facility.1,2 In 1970, Reed and Ford 
opened the first stand-alone surgery centre in Phoenix, 
Arizona.1 This was followed by a tremendous growth period 
in the USA, with 240 ambulatory surgery centres in 1983, 
which increased to 5 174 by 2008. In 1984, the Society for 
Ambulatory Anesthesia (SAMBA) was formed as the first 
specialty society dedicated to ambulatory anaesthesia. 
The drivers for this phenomenal growth can be summarised 
as:
•	 The development of anaesthetic drugs and surgical 
technologies which enabled rapid recovery, allowing 
patients to be discharged home.
•	 Pressure to reduce healthcare costs.
•	 The demonstration that ambulatory surgery and 
anaesthesia was safe (possibly safer than inpatient 
surgery).
•	 Patient preference not to be admitted to hospital.
In the early 1960s, fentanyl and droperidol were first 
introduced, and played an important role in the opening 
of the ambulatory surgery centre at George Washington 
University.3 The development of drugs for ambulatory 
anaesthesia, i.e. short-acting neuromuscular blockers, short 
acting opiates, newer volatile anesthetics and propofol was 
very important for its growth. Propofol soon followed. In 
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addition, major drug advances were made to minimise the 
adverse outcomes of surgery, i.e. pain and postoperative 
nausea and vomiting (PONV). Simultaneously, there 
were tremendous advances in endoscopic technologies. 
Ambulatory centres rapidly demonstrated markedly 
enhanced efficiency in performing surgeries. This translated 
into 40-50% cost savings for the same procedure 
performed in a hospital.2 In the early 1970s, only 35% of 
payers covered ambulatory surgery in the USA, but 95% 
payers covered these procedures a decade later. 
The management of ambulatory surgical centres has 
become a sophisticated science and business. Advances 
in anaesthesia and surgical technology continue to be 
seen. The growth of imaging techniques, and the need 
for sedation and anaesthesia for procedures that utilise 
these sophisticated imaging systems, have both become 
an important part of ambulatory anaesthesia. At the same 
time, patients have fuelled this demand for sedation during 
procedures that are either mild to moderately uncomfortable, 
or which take hours to perform. Recently, surgeries and 
procedures have started to move out of the ambulatory 
surgery centre and into the physician office. This presents 
a new challenge to the provision of safe anaesthetic care. 
Patient safety
Initially, there was great concern with regard to patient safety 
when procedures were performed in an ambulatory centre. 
It became apparent that this was safer for patients because 
infection rates were lower when patients were kept out of 
the hospital.1,2 Several studies showed zero morbidity or rare 
death within 30 days of surgery in an ambulatory surgery 
centre, and readmission rates of less than 1%. Fleisher et al 
reviewed the Medicare database from 1994-1999 and found 
that the overall rate of adverse events leading to admission 
to the emergency department or hospital was lowest in a 
free-standing ambulatory surgery centre, compared to a 
hospital-based ambulatory surgery centre or physician 
office.4 They also found that the risk of an adverse event 
occurring was closely linked to the type of surgery. The 
highest risk was with an umbilical hernia and transurethral 
prostate resection, and the lowest with haemorrhoidectomy 
and cataract surgery. Fleischer et al also developed a risk 
index for admission following ambulatory surgery from a 
similar Medicare database.5 The component risk factors 
were general anaesthesia (two points), surgery lasting longer 
than 120 minutes, a medical history of cardiac or peripheral 
vascular disease, cerebrovascular disease, malignancy and 
being human immunodeficiency virus-positive, regional 
anaesthesia and age > 65 years (all one point). The odds 
ratio for admission is three times greater for a score > 3, 
than one of 1 or less.  
Patients also expressed a preference for having their surgery 
in an ambulatory surgical centre. Ninety-eight per cent of 
patients were satisfied with ambulatory surgery centres, 
compared with 94% who were content with hospitals, in a 
Centers for Medicaid and Medicare Services (CMS) study. 
They ascribed their preferences to: 
•	 Less paperwork.
•	 Lower costs and a more convenient location. 
•	 Parking. 
•	 No waiting at the ambulatory surgery centre.
•	 More organised and friendlier staff.
With safety established, greater emphasis was placed on 
less severe yet more frequent adverse outcomes, quality 
of life and patient satisfaction. Significant advances in 
the management of PONV were observed with this focus 
because of a slew of new antiemetics and the publication 
of PONV management guidelines.6 SAMBA also developed 
guidelines for PONV, diabetic management, obstructive 
sleep apnoea, malignant hyperthermia and obesity.6-10 
Often, small steps taken from the time of the patient’s 
visit through to discharge will markedly enhance patient 
satisfaction and reduce the impact of adverse events on the 
patient’s experience.
The future of ambulatory anaesthesia
Ambulatory anaesthesia developed exponentially over 
the first 50 years. Significant growth and change will 
continue into the future. Change was driven largely by the 
introduction of new anaesthesia drugs and techniques. The 
future of ambulatory anaesthesia will probably be driven 
by advances in technology, largely in surgery, but also in 
anaesthesia. 
The greatest change in ambulatory surgery and anaesthesia 
is likely to be the growth of surgeries and procedures which 
are performed in an ambulatory environment, and which 
specifically focus on the movement of surgeries out of the 
operating room into the office. Technological advances 
in imaging devices and surgical instrumentation, such as 
catheters or robotics, are helping to drive these changes. 
Office-based surgery is likely to continue to grow extensively 
for many years to come. This is driven by increased surgeon 
convenience, lower costs, patient convenience and 
advances in surgical instrumentation technology. Although 
basic anaesthetic management in the office remains similar 
to that in an ambulatory centre, this site of anaesthetic 
delivery presents multiple unique challenges. These include 
the lack of regulatory oversight of office-based surgery, 
anaesthetic delivery machines and devices, preoperative 
assessment and postoperative recovery, the scope of 
the surgical procedure, and lastly the appropriateness of 
patients having the procedure in an office-based setting. 
Similar growth of ambulatory anaesthesia is being delivered 
in radiology suites, electrophysiology and cardiology 
laboratories in a hospital setting. 
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Who provides anaesthesia services will be a great challenge 
in the future. Other medical specialties are practising some 
aspect of anaesthesia; and dentists, nurses and technicians 
developing anaesthesia training programmes. Sedasys® is 
a device which provides sedation through a closed-loop 
system with built-in safety alarms, thus minimising the 
need for an anaesthesia provider in procedures where only 
moderate sedation is required.11
In the USA, there is increasing pressure from payers, 
especially the government, to link payment to quality. Several 
programmes have been introduced, both at physician and 
facility level. Recently, six quality measures were introduced 
which need to be reported. Failure to report these measures 
reduces reimbursement. 
SAMBA initiated its Clinical Outcomes Registry (SCOR) 
with the objective of enhancing patient safety by collecting 
specific patient data points. Data include preoperative 
history, procedures, providers, intraoperative anaesthetic 
management, postoperative management, outcomes and 
patient satisfaction. Presently, there are close to 100 000 
patients from over 25 centres. This allows benchmarking 
quality metrics and helps with the development of 
best practice. As an example, using this database, we 
demonstrated the value of administering prophylactic 
antiemetics equal to the number of Apfel risk criteria to 
minimise postoperative PONV.12 
Technology is driving major changes in optimising 
preoperative assessment, with increasing emphasis on 
distant acquisition of preoperative information through 
web-based questionnaires and telemedicine.  
New drug development continues with short-acting sedatives 
(remimazolam), neuromuscular blockers (AV430A), reversal 
agents (cysteine), and newer analgesics (adenosine), as well 
as local anaesthetics. Similarly, developments will continue 
in anaesthesia equipment, such as drug-delivery systems, 
airway devices, video laryngoscopes and equipment for 
regional anaesthesia. 
The development of technology for surgical procedures 
will be the biggest driver that will change the future of 
anaesthesia. The primary purpose of these technologies is to 
make surgery less invasive. Currently, they include advances 
in catheters, robotics, three-dimensional imaging and 
advances in endoscopic equipment. Advances will not only 
drive surgeries from an inpatient setting to the ambulatory 
environment, but also from the ambulatory environment to 
the office. Improvements in surgical technology are likely 
to increase the overall volume of procedures which require 
anaesthetic care. As procedures become less invasive, 
anaesthesia will continue to be pushed in the direction 
of sedation and regional anaesthesia, rather than general 
anaesthesia. Intraoperative perturbations in physiology are 
likely to be less. However, an older and potentially sicker 
population will become a feature in the ambulatory surgical 
environment.
The future of ambulatory anaesthesia remains robust 
following the tremendous growth that ambulatory 
anaesthesia has experienced in the last 50 years. The 
primary driver has been advances in surgical technology. 
This is likely to increasingly drive surgeries out of the hospital 
into the ambulatory environment, and especially into the 
office or imaging suites. The SAMBA SCOR project is likely 
to help best practice for ambulatory anaesthesiology to be 
developed to further enhance safety and quality of life. 
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